The first has shown antitumoral effects against prostate cancer and melanoma with a consistently higher activity on cancer with respect to normal cells (18,33), the second is a small molecule disrupting nucleolin/rDNA G4 complexes in the nucleolus, thereby impairing ribosome biogenesis and inducing apoptosis in cancer cells (34). Here, NUCLEOLIN is linked to melanoma.